Exercise and the dipeptidyl-peptidase IV inhibitor sitagliptin do not improve beta-cell function and glucose homeostasis in long-lasting type 1 diabetes-A randomised open-label study.

Endocrinol Diabetes Metab · 2019 · PMC6613228 · PMID 31294088

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)

Interestingly, there was an increase in AUC C‐peptide after a 12‐week treatment period as compared to baseline in the group with sitagliptin only, but it did not reach statistical significance ( P = 0.07, Figure S1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.